ArticleInternational urogynecology journal2026
Redefining "Level of Involvement": A Stage-Based Governance Framework for Pelvic Organ Prolapse Innovation.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Innovation in pelvic organ prolapse surgery depends on early, iterative collaboration among clinicians, engineers, companies, universities, and professional societies. After past device-related harms, many organizations adopted restrictive rules to prevent undue influence, but these can unintentionally exclude the physician innovators best positioned to guide safe progress. We propose a proportional governance framework that scales with technological maturity (technology readiness level, TRL), clinical validation (clinical readiness level, CRL), and physician financial or decisional influence (level of involvement, LOI) across four stages: discovery, translational innovation, clinical validation, and commercial deployment. A practical governance scorecard and a standardized research lexicon (completed, ongoing, planned) support management rather than exclusion, preserving transparency and patient protection while enabling responsible innovation.
Indexed as
Identifiers
42606713What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.